Innovation Pharmaceuticals Inc (IPIX)

[Justfactsmam]

Incorrect Statement: "Science is half of the success and management is the other half..." you forgot CAPITAL!

A Company can have:
1. the "Science" to prove out...and requires FDA approval in order to translate to Equity Value, (IPIX/Brilacidin)
2. They can have the "Management" to move it forward (Leo/DeGrado)...
3. but with no "Capital" ... nothing moves forward.

Without the Capital to move forward...the statement and/or suggestions that: "Follow the Money" is a MEASURE of Success or Failure at this stage of a drug development company is also an erroneous assertion based on a false assumption.

Without ALL three...the Science and product does not move forward. That was IPIX and Brilacidin...until 2020...

NOW...Leo has put the Third Leg on the stool...raised the capital for Brilacidin/Covid-19 AND other INDICATIONS...and has put BRILACIDIN in the bullseye of FDA.

SO THE PROCESS IS "FOLLOW THE SCIENCE"... "THEN FOLLOW THE MONEY"!

So right now... "Follow the Science"...

... which has been nothing but "STELLAR"...through RBL testing and giving it FDA recognition via Fast Track authorization and Investigational New Drug designation...leading to the CURRENT FDA CLINICAL TRIALS...

... listen to the PR and little birdies tweet "Alpha Viruses" and you will realize eyeballs are on Brilacidin for much bigger trophies than Covid-19 and its Variants...and

...wait for the Current clinical trial results...which dosing has been authorized to increase from 3 to 5 days of dosing to match Remdesivir protocol of 5 days and SoC in many U.S hospitals.

...THEN YOU CAN FOLLOW THE MONEY!!! (but of course, at a much greater price)

Upon demonstration in Phase II of success in disposing of ALL VARIANTS (since they are all Enveloped Viruses) and RBL testing showing high efficacy with ALPHA VIRUSES...

...IMO look for NOT "FOLLOW THE MONEY" ...but "CHASING THE MONEY" at over 20X, that is... $5.00 AS STARTERS and that's IMO a MINIMUN!